Low-dose danaparoid sodium catheter flushes in an intensive care infant suffering from heparin-induced thrombocytopenia

Pediatric Critical Care Medicine

Volumn 2, Issue 2, 2001, Pages 175-177

  Ranze, Oliver ^a   Rakow, Alexander ^a   Ranze, Petra ^a   Eichler, Petra ^a   Greinacher, Andreas ^a   Fusch, Christoph ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Catheter; Danaparoid; Heparin; Heparin induced thrombocytopenia; Platelet; Thrombosis

Indexed keywords

EID: 0344821098     PISSN: 15297535     EISSN: 19473893     Source Type: Journal    
DOI: 10.1097/00130478-200104000-00013     Document Type: Article

References (18)

1. Greinacher A: Antigen generation in heparin-associated thrombocytopenia: The nonimmunologic type and the immunologic type are closely linked in their pathogenesis. Semin Thromb Hemost 1995; 21: 106-116
2. Warkentin TE, Levine MN, Hirsh J, Horsewood P, et al: Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 1995; 332: 1330-1335
3. Spadone D, Clark F, James E, et al: Heparin-induced thrombocytopenia in the newborn. J Vasc Surg 1992; 15: 306-311
4. Kadidal VV, Mayo DJ, Horne MK: Heparin-induced thrombocytopenia (HIT) due to heparin flushes: A report of three cases. J Intern Med 1999; 246: 325-329
5. Ranze O, Ranze P, Magnani HN, et al: Heparin-induced thrombocytopenia in pediatric patients—a review of the literature and a new case treated with danaparoid sodium. Eur J Pediatr 1999; 158: 130-133
6. Arepally G, Cines DB: Heparin-induced thrombocytopenia and thrombosis. Clin Rev Allergy Immunol 1998; 16: 237-247
7. Chong BH: Danaparoid for the treatment of heparin-induced thrombocytopenia. In: Heparin-induced Thrombocytopenia. Warkentin TE, Greinacher A (Eds). New York, Marcel Decker, 2000, pp 291-311
8. Saxon BR, Black MD, Edgell D, et al: Pediatric heparin-induced thrombocytopenia: Management with danaparoid (Orgaran). Ann Thorac Surg 1999; 68: 1076-1078
9. Schiffmann H, Unterhalt M, Harms K, et al: Erfolgreiche behandlung einer heparin-induzierten thrombozytopenie typ II im kindesalter mit rekombinantem hirudin. Monatsschr Kinderheilkd 1997; 145: 606-612
10. Wilhelm MJ, Schmid C, Kececioglu D, et al: Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia using Org 10172. Ann Thorac Surg 1996; 61: 920-924
11. Danhof M, de Boer A, Magnani HN, et al: Pharmacokinetic considerations on Orgaran (Org 10172) therapy. Haemostasis 1992; 22: 73-84
12. Magnani HN: Orgaran (Danaparoid sodium) use in the syndrome of heparin-induced-thrombocytopenia. Platelets 1997; 8: 74-81
13. Greinacher A, Amiral J, Dummel V, et al: Laboratory diagnosis of heparin-associated thrombocytopenia and comparison of platelet aggregation test, heparin-induced platelet activation test, and platelet factor 4/heparin enzyme-linked immunosorbent assay. Transfusion 1994; 34: 381-385
14. Warkentin TE: Heparin-induced thrombocytopenia: Pathogenesis, frequency, avoidance and management. Drug Saf 1997; 17: 325-341
15. Magnani HN, Beijering RJR, ten Cate JW, et al: Orgaran anticoagulation for cardiopulmonary bypass in patients with heparin-induced thrombocytopenia. In: New anticoagulants for the cardiovascular patient. Pifarré R (Ed). Philadelphia, Hanley & Belfus, 1997, pp 487-500
16. Greinacher A, Völpel H, Janssens U, et al: Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: A prospective study. Circulation 1999; 99: 73-80
17. Greinacher A, Janssens U, Berg G, et al: Lepirudin (Recombinant hirudin) for parenteral anticoagulation in patients with heparin-induced thrombocytopenia. Circulation 1999; 100: 587-593
18. Greinacher A, Warkentin TE: Treatment of Heparin-induced thrombocytopenia. An overview. In: Heparin-induced thrombocytopenia. Warkentin TE, Greinacher A. (Eds). New York, Marcel Dekker Inc., 2000, pp 261-290